Health Matters | To Protect Its Image in Pharmacy World, India Should Shut Firms Who Don't Comply

China has massively upgraded its pharma manufacturing practices, involving display of political willpower and commitment of health regulators. India will also implement Schedule M, which is the local version of WHO-GMP – basic requirements for drugmakers

Related Keywords

Uzbekistan ,China ,Gambia ,Madhya Pradesh ,India ,Uttarakhand ,Uttaranchal ,Haryana ,Kerala ,Delhi ,Himachal Pradesh ,Mansukh Mandaviya ,World Health Organization ,Department Of Biotechnology ,European Medicines Agency ,Ministry Of Health ,Central Drugs Standard Control Organisation ,Cnn ,Family Welfare ,Good Manufacturing Practices ,Till June ,International Council ,Technical Requirements ,Human Use ,Drug Controller General ,Starting October ,Pharmaceutical Inspection Co Operation Scheme ,Health Matters ,Indian Pharmaceutical Industry ,